Despite their potential, nanotechnology-based diagnostic tools face several challenges:
Regulatory Hurdles: Ensuring safety and efficacy requires rigorous testing and approval processes. Scalability: Manufacturing these tools on a large scale can be complex and costly. Biocompatibility: Ensuring that nanoparticles do not induce adverse immune responses. Data Management: Handling and interpreting large volumes of data generated by these tools.
